Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/6696 stock hub

TPEX/6696 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6696is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

32.5B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6696

In the news

Latest news · TPEX/6696

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-16.9

P25 -16.2P50 0.3P75 9.8

ROIC-11.7

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6696 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

TWD

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 30.6B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0006696008
Last refreshed	2026-05-10
Market cap	TWD 32.5B
Price	TWD 390
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/6696
Website	https://www.linbioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.19%
EV Earnings	-22.48x
EV/FCF	-21.15x
FCF yield	-4.46%
P/B ratio	1.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	TWD -1.4B
Net Income Growth Years	0%
ROA	-11.54
Roa5y	-19.29
ROCE	-11.36
ROE	-16.93
Roe5y	-39.84
ROIC	-11.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	236.49%
Cagr3y	33.61%
Cagr5y	11.51%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	TWD 25.4B
Cash	TWD 16.3B
Current Assets	TWD 5.3B
Current Liabilities	TWD 129.6M
Debt	TWD 22.8M
Debt Equity	TWD 0
Debt FCF	TWD -0.02
Equity	TWD 25.1B
Interest Coverage	-2,812
Liabilities	TWD 291.2M
Long Term Assets	TWD 20.1B
Long Term Liabilities	TWD 161.6M
Net Cash	TWD 16.3B
Net Cash By Market Cap	TWD 50.04
Net Cash Growth	25.82%
Net Debt Equity	TWD -0.65
Tangible Book Value	TWD 10.6B
Tangible Book Value Per Share	TWD 128
WACC	5.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	58.18
Net Working Capital	TWD -105M
Quick ratio	57.68
Working Capital	TWD 16.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.46%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	236.21%
200-day SMA	302.8
3Y total return	138.57%
50-day SMA	401
50-day SMA vs 200-day SMA	50over200
5Y total return	72.39%
All Time High	510
All Time High Change	-23.53%
All Time High Date	2026-04-22
All Time Low	27
All Time Low Change	1,344.44%
All Time Low Date	2019-11-18
ATR	19.2
Beta	0.23
Beta1y	0.33
Beta2y	0.45
Ch YTD	-1.76
High	396
High52	510
High52 Date	2026-04-22
High52ch	-23.53%
Low	383
Low52	113
Low52 Date	2025-05-08
Low52ch	251.35%
Ma50ch	-2.74%
Price vs 200-day SMA	28.82%
RSI	43.91
RSI Monthly	68.35
RSI Weekly	59.44
Sharpe ratio	2.12x
Sortino ratio	4.78
Total Return	-4.46%
Tr YTD	-1.76
Tr1m	-2.5%
Tr1w	-4.06%
Tr3m	-2.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -2.9B

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	64,368,472%
Net Borrowing	-16,421,000
Shares Insiders	19.07%
Shares Institutions	4.17%
Shares Out	82,725,000
Shares Qo Q	3.61%
Shares Yo Y	4.46%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -2.7B
Average Volume	787,107x
Bv Per Share	129.7
CAPEX	TWD -7.2M
Ch1m	-2.5
Ch1w	-4.06
Ch1y	236.2
Ch3m	-2.38
Ch3y	133.5
Ch5y	67.38
Ch6m	33.11
Change	-1.14%
Change From Open	-1.14
Close	394.5
Days Gap	0
Depreciation Amortization	23,785,000
Dollar Volume	158,205,450
Earnings Date	2026-05-12
EBIT	TWD -2.9B
EBITDA	TWD -2.8B
EPS	TWD -16.6
F Score	1
FCF	TWD -1.4B
FCF EV Yield	-4.73x
FCF Per Share	TWD -17.51
Financing CF	20,481,159,000
Fiscal Year End	December
Income Tax	TWD -55.3M
Investing CF	-9,363,609,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-06-30
Ma150	352.2
Ma150ch	10.72%
Ma20	418.1
Ma20ch	-6.73%
Net CF	10,420,235,000
Next Earnings Date	2026-05-12
Open	394.5
Position In Range	53.85
Ppne	40,502,000
Price Date	2026-05-08
Ptbv Ratio	3.06
Relative Volume	0.5x
Share Based Comp	1,203,581,000
Tr6m	33.11%
Volume	405,655

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6696 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6696 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6696?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.2%

Share of float held by funds and institutions

Insider ownership

+19.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.5%

Negative means the company is buying back shares.

Technical

TPEX/6696 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.9

Neutral momentum band

Price vs 200-day MA

+28.8%

50/200-day relationship not available

Beta (5Y)

0.23

Less volatile than the market

Sharpe ratio

2.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6696

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6696 stock rating?

tpex/6696 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6696 analysis?

The full report lives at /stocks/tpex/6696/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6696?

The latest report frames tpex/6696 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6696 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.